mefloquine is used to both prevent and treat certain forms of malaria mefloquine is useful for the prevention of malaria in all areas except for those where parasites may have resistance to multiple medications , and is one of several anti-malarial medications recommended by the united states centers for disease control and prevention for this purpose it is also recommended by the infectious disease society of america for malaria prophylaxis as a first or second-line agent , depending on resistance patterns in the malaria found in the geographic region visited if a person becomes ill with malaria despite prophylaxis with mefloquine , the use of halofantrine and quinine for treatment may be ineffective mefloquine is used as a treatment for chloroquine-sensitive or resistant plasmodium falciparum malaria , and is deemed a reasonable alternative for uncomplicated chloroquine-resistant plasmodium vivax malaria it is one of several drugs recommended by the united states ' centers for disease control and prevention common side effects include vomiting , diarrhea , headaches , and a rash severe side effects requiring hospitalization are rare , but include mental health problems such as depression , hallucinations , anxiety and neurological side effects such as ataxia , seizures , and tinnitus mefloquine is therefore not recommended in people with a history of psychiatric disorders or epilepsy in 2013 the fda stated '' neurologic side effects can occur at any time during drug use , and can last for months to years after the drug is stopped or can be permanent psychiatric effects include nightmares , visual hallucinations , auditory hallucinations , anxiety , depression , unusual behavior , and suicidal ideations central nervous system events requiring hospitalization occur in about one in 10,000 people taking mefloquine for malaria prevention , with milder events ( e.g compared to other malaria chemoprophylaxis regimens , however , mefloqinone may produce more side effects in non-pregnant travelers the world health organization ( who ) gives approval for the use of mefloquine in the second and third trimesters of pregnancy and use in the first trimester does not mandate termination of pregnancy by 1994 , medical professionals were noting '' severe psychiatric side effects observed during prophylaxis and treatment with mefloquine '' , and recommending that '' the absence of contraindications and minor side effects during an initial course of mefloquine should be confirmed before another course is prescribed canadian soldiers who took mefloquine when deployed overseas have claimed they have been left with ongoing mental health problems 